Related Experiment Video

Updated: Jun 17, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

[Photodynamic therapy: search for ideal photosensitizer]

N V Kudinova, T T Berezov

    Biomeditsinskaia Khimiia
    |December 19, 2009
    PubMed

    Insights

    Photodynamic therapy (PDT) offers a selective, minimally invasive cancer treatment by using photosensitizers to generate cell-killing reactive oxygen species. This review covers PDT sensitizer generations, their effectiveness, and future advancements in cancer therapy.

    Area of Science:

    • Oncology
    • Biochemistry
    • Medical Physics

    Context:

    • Photodynamic therapy (PDT) is an emerging cancer treatment modality.
    • It utilizes photosensitizers for targeted tumor destruction.
    • PDT also aids in fluorescent diagnostic imaging of cancer.

    Purpose:

    • To review the first and second generations of photosensitizers used in PDT.
    • To discuss their photosensitizing capabilities and limitations.
    • To explore future directions in PDT research and application.

    Summary:

    • PDT involves the selective accumulation of photosensitizers in tumor cells.
    • Photosensitization generates cytotoxic reactive oxygen species, leading to tumor cell death.
    • Key advantages include high selectivity and reduced toxicity compared to conventional therapies.

    Impact:

    • Highlights the potential of PDT as a superior cancer treatment option.
    • Identifies areas for improvement in photosensitizer development.
    • Suggests broadening the applications of photodynamic therapy in oncology.

    More Related Videos

    An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model11:04

    An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

    Published on: January 13, 2023

    An In Vitro Approach to Photodynamic Therapy04:53

    An In Vitro Approach to Photodynamic Therapy

    Published on: August 17, 2018

    Related Concept Videos

    Photosystem I01:27

    Photosystem I

    Although structurally similar to photosystem II (PSII), photosystem I (PSI) is has a different electron supplier and electron acceptor.
    Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...
    Photosystem II01:22

    Photosystem II

    The multi-protein complex photosystem II (PS II) harvests photons and transfers their energy through its bound pigments to its reaction center, and ultimately to photosystem I (PSI) through the electron transport chain. The pigments responsible for caputirng the light energy in photosystems include chlorophyll a, chlorophyll b, and carotenoids.
    The pigment molecules are arranged across  two photosystem domains — the antenna complex and the reaction center. The main aim of the pigment molecules...
    Photochemical Electrocyclic Reactions: Stereochemistry01:26

    Photochemical Electrocyclic Reactions: Stereochemistry

    The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
    Selection Rules: Photochemical Activation